arrow
G

Giovanni Luca Ceresoli

humanitas gavazzeni clinic
H指数:49
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

CHIMERA: a phase II study of neoadjuvant pembrolizumab in combination with cisplatin or carboplatin and pemetrexed followed by surgery and adjuvant pembrolizumab in resectable pleural mesothelioma

CHIMERA:一项关于新辅助培美曲塞联合顺铂或卡铂和培美曲塞,随后进行手术及辅助培美曲塞治疗可切除胸膜间皮瘤的II期研究

2026-05-270
OAAI
Pericardial Mesothelioma: Diagnostic and Therapeutic Management, a Population-Based Study in Italy

心包间皮瘤:诊断与治疗管理——一项意大利基于人群的研究

Cancers
IF4.4
2026-03-040
OAAI
Perioperative Treatments in Pleural Mesothelioma: State of the Art and Future Directions

Cecchi, L.G.; Aliprandi, M.; De Vincenzo, F.; Perrino, M.; Cordua, N.; Borea, F.; Bertocchi, A.; Federico, A.; Marulli, G.; Santoro, A.; 等. 胸膜间皮瘤的围手术期治疗:现状与未来方向. Cancers 2025, 17, 3199. [Google Scholar] [CrossRef]

Cancers
IF4.4
2026-03-030
OAAI
Real-life management of stage III non-small cell lung cancer patients in Italy: the BE-PACIFIC observational study

意大利III期非小细胞肺癌患者的真实世界管理:BE-PACIFIC 观察性研究

2026-01-010
OAAI
Diagnostic and Therapeutic Management of Mesothelioma of the Tunica Vaginalis Testis: A Population-Based Study in Italy

睾丸鞘膜间皮瘤的诊断与治疗管理:一项意大利基于人群的研究

2025-10-070
OAAI
Heterogeneity of progression-free survival surrogacy by sex in randomized trials testing immunotherapy in non-small cell lung cancer

非小细胞肺癌免疫治疗随机试验中,按性别划分的无进展生存期代理终点异质性

2025-10-010
OAAI
Oligometastatic Mesothelioma Treated with Ablative Radiotherapy (OMAR): A Multicenter Study

寡转移性间皮瘤经消融放疗治疗(OMAR):一项多中心研究

2025-08-270
OA
Sex hormones, the anticancer immune response, and therapeutic opportunities

性激素,抗癌免疫反应和治疗机会

2025-03-011
OAAI
Outcomes of patients with advanced solid tumors who discontinued immune-checkpoint inhibitors: a systematic review and meta-analysis

停用免疫检查点抑制剂的晚期实体瘤患者的结局: 系统回顾和荟萃分析

2024-07-010
OAAI
Management of patients with extensive small-cell lung cancer in the immunotherapy era: An Italian consensus through a Delphi approach

免疫治疗时代广泛小细胞肺癌患者的管理: 通过Delphi方法达成的意大利共识

2024-07-011
PRE
BAP1 Loss, Nuclear Grading, and Nonepithelioid Features in the Diagnosis of Mesothelioma in Italy: Nevermore without the Pathology Report

意大利间皮瘤诊断中的BAP1丢失,核分级和非上皮样特征: 没有病理报告的情况

2024-04-082
OA
Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France: a phase 3, open-label, randomised controlled trial
LANCET
IF88.5
2023-12-0113
PRE
Phase 2-3 trial of pegargiminase plus chemotherapy versus placebo plus chemotherapy in patients with non-epithelioid pleural mesothelioma
2023-04-144
PRE